Skip to content
HowShorted

Arcturus Therapeutics Holdings Inc. short interest in 2020

In 2020, Arcturus Therapeutics Holdings Inc.'s disclosed short interest ran from 1.04% of shares outstanding on 15 Jan 2020 to 12.94% on 31 Dec 2020, a change of +11.90 percentage points. The year's high was 19.14% on 13 Nov 2020 and its low 0.98% on 31 Jan 2020, averaging 8.16% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.84 days on 30 Oct 2020. Full history: Arcturus Therapeutics Holdings Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Arcturus Therapeutics Holdings Inc. in 2020

2020 in figures

Start of year
1.04% (15 Jan 2020)
End of year
12.94% (31 Dec 2020)
Change
+11.90 pp
High
19.14% (13 Nov 2020)
Low
0.98% (31 Jan 2020)
Average
8.16%
Highest days to cover
11.84 (30 Oct 2020)
SEC filings marked
8

Every report in 2020

Arcturus Therapeutics Holdings Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20201.04%2.04
31 Jan 20200.98%3.49
14 Feb 20201.16%2.67
28 Feb 20200.99%1.48
13 Mar 20201.32%1.00results (8-K)
31 Mar 20201.40%1.0010-K filed
15 Apr 20202.21%1.99
30 Apr 20202.81%1.00
15 May 20202.94%1.00results (8-K), 10-Q filed
29 May 20203.10%1.00
15 Jun 20206.95%1.82
30 Jun 202012.91%1.99
15 Jul 20208.13%1.64
31 Jul 202010.93%1.98
14 Aug 20206.46%2.5810-Q filed, results (8-K)
31 Aug 20206.31%2.74
15 Sep 20209.14%3.14
30 Sep 202015.53%5.14
15 Oct 202017.02%8.89
30 Oct 202018.49%11.84
13 Nov 202019.14%3.6610-Q filed, results (8-K)
30 Nov 202018.73%6.84
15 Dec 202015.11%2.28
31 Dec 202012.94%1.02

See also: Arcturus Therapeutics Holdings Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.